Clinical utility of a novel concentrated enteral formula in patients undergoing colorectal cancer surgery: A randomized controlled trial

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 11

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Gastrointest Surg. Nov 27, 2025; 17(11): 112557
Published online Nov 27, 2025. doi: 10.4240/wjgs.v17.i11.112557

Table 4 The effect of actual oral calorie intake on the incidence of surgical site infections

	Nutritional intervention group (n = 17)			Non-intervention group (n = 18)			Comparison of odds ratio between groups
	Odds ratio	95%CI	P value	Odds ratio	95%CI	P value	P value
Oral intake pre-op-2	0.58	0.24-1.32	0.1849	1.06	0.81-1.40	0.6705	0.1637
Oral intake pre-op-1	0.78	0.57-1.06	0.1176	1.04	0.86-1.26	0.6562	0.0994
Oral intake pre-op-2 to-1	0.88	0.72-1.08	0.2228	1.00	0.91-1.13	0.6231	0.0955

CI: Confidence interval; Op: Operation.

Citation: Shinji S, Yamada T, Matsuda A, Uehara K, Yokoyama Y, Takahashi G, Iwai T, Miyasaka T, Kanaka S, Hayashi K, Yoshida H. Clinical utility of a novel concentrated enteral formula in patients undergoing colorectal cancer surgery: A randomized controlled trial. World J Gastrointest Surg 2025; 17(11): 112557
URL: https://www.wjgnet.com/1948-9366/full/v17/i11/112557.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i11.112557

Shinji S, Yamada T, Matsuda A, Uehara K, Yokoyama Y, Takahashi G, Iwai T, Miyasaka T, Kanaka S, Hayashi K, Yoshida H. Clinical utility of a novel concentrated enteral formula in patients undergoing colorectal cancer surgery: A randomized controlled trial. World J Gastrointest Surg 2025; 17(11): 112557 [PMID: 41357654 DOI: 10.4240/wjgs.v17.i11.112557]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.